# A B C D E F G H I J K L M N O P Q R S T U V W X Y Z

Finding useful health information on the Internet can be difficult, but we’re here to help. This page gathers quality information from trusted sources. You can learn more about the disease, visit handpicked websites, and find resources to help you in your daily life. Need more information? Click the menu on the left to find more!

 

Ovarian cancer

Cancer, Ovarian
Get Update

Clinical Trials

This information is provided by ClinicalTrials.gov

Search Clinical Trials
Displaying 11-20 of 2723 results.
Chiauranib in Combination With Chemotherapy in Patients With Ovarian Cancer
Status: Active, not recruiting
Last Changed: Aug 06, 2020
First Received: Apr 03, 2019
Disease(s): Ovarian Cancer
Intervention(s): chiauranib, etoposide, paclitaxel
Locations: Fudan University Shanghai Cancer Center, Shanghai, China
An Observational Study of Combination of Pegylated Liposomal Doxorubicin and Trabectedin in Routine Practice in Patients With Recurrent Partial-platinum Sensitive Ovarian Cancer
Status: Unknown status
Last Changed: Feb 26, 2018
First Received: Feb 26, 2018
Disease(s): Ovarian Cancer
Intervention(s): Trabectedin + PLD
Locations: Almaty oncological center, Almaty, Kazakhstan
Almaty regional oncological dispensary, Almaty, Kazakhstan
Kazakh institute of oncology and radiology, Almaty, Kazakhstan
Kazakh institute of oncology and radiology, Almaty, Kazakhstan
Astana Oncology Center, Astana, Kazakhstan
... and 6 other locations.
Efficacy and Safety Study of AVB-S6-500 in Patients With Platinum-Resistant Recurrent Ovarian Cancer
Status: Active, not recruiting
Last Changed: Oct 08, 2020
First Received: Aug 21, 2018
Disease(s): Ovarian Cancer
Intervention(s): AVB-S6-500, Paclitaxel (Pac), Pegylated liposomal doxorubicin (PLD), Placebo
Locations: Arizona Oncology, Phoenix, Arizona, United States
Arizona Oncology Associates, Tucson, Arizona, United States
Kaiser Permanente Oakland, Oakland, California, United States
Kaiser Permanente Roseville, Roseville, California, United States
Kaiser Permanente San Francisco, San Francisco, California, United States
... and 12 other locations.
Oxford Ovarian Cancer Predict Chemotherapy Response 01
Status: Unknown status
Last Changed: Jan 17, 2013
First Received: Jan 17, 2013
Disease(s): Ovarian Cancer
Locations: Churchill Hospital, Oxford, United Kingdom
A Single-Center, Phase I Clinical Study to Evaluate the Safety, Tolerability, and Efficacy of LCAR-M23, a CAR-T Cell Therapy Targeting MSLN in Patients With Relapsed and Refractory Epithelial Ovarian Cancer
Status: Not yet recruiting
Last Changed: Sep 24, 2020
First Received: Sep 24, 2020
Disease(s): Epithelial Ovarian Cancer
Intervention(s): LCAR-M23 cells
Locations: Shanghai East Hospital, Shanghai, Shanghai, China
Engineered Immune Effectors Against Ovarian Cancer
Status: Recruiting
Last Changed: Sep 19, 2019
First Received: Dec 05, 2017
Disease(s): Ovarian Cancer
Intervention(s): OC-CTLs
Locations: Jinshazhou Hospital of Guangzhou University of Chinese Medicine, Guangzhou, Guangdong, China
Shenzhen Geno-immune Medical Institute, Shenzhen, Guangdong, China
Yunnan Cancer Hospital & The Third Affiliated Hospital of Kunming Medical University & Yunnan Cancer Center, Kunming, Yunnan, China
SGI-110 in Combination With Carboplatin in Ovarian Cancer
Status: Completed
Last Changed: Jan 18, 2020
First Received: Sep 28, 2012
Disease(s): Ovarian Cancer
Intervention(s): SGI-110, Treatment of Choice ( topotecan, pegylated liposomal doxorubicin, or paclitaxel), Carboplatin
Locations: Norris Comprehensive Cancer Center- University of Southern California, Los Angeles, California, United States
University of Florida Shands Cancer Center, Gainesville, Florida, United States
Georgia Health Sciences University, Augusta, Georgia, United States
University of Chicago, Chicago, Illinois, United States
Melvin and Bren Simon Cancer Center- Indiana University, Indianapolis, Indiana, United States
... and 20 other locations.
Efficacy of Letrozole in Recurrent Ovarian Cancer
Status: Not yet recruiting
Last Changed: Jun 09, 2020
First Received: Jun 09, 2020
Disease(s): Epithelial Ovarian Cancer
Intervention(s): Letrozole 2.5mg, Standard single agent chemotherapy
Pazopanib and Weekly Topotecan in Patients Recurrent Ovarian Cancer (TOPAZ)
Status: Unknown status
Last Changed: Oct 11, 2016
First Received: May 17, 2012
Disease(s): Ovarian Cancer
Intervention(s): pazopanib in combination with weekly topotecan
Locations: Charité Campus Virchow-Klinikum, Berlin, Germany
The Preoperative Predictors of Optimal Cytoreductive Surgery in Women With Advanced Ovarian Cancer
Status: Completed
Last Changed: Aug 05, 2016
First Received: Aug 05, 2016
Disease(s): Ovarian Cancer